The aim of this narrative review is to summarize recent knowledge about the diagnostic significance of immunobiological detection of C3d with a focus on renal and skin tissue biopsies. We completed the present narrative review with our own experiences with preparation and practical use of monoclonal C3d antibodies at a small national level.

DB Biotech a s Košice Slovak Republic

Zobrazit více v PubMed

Toapanta FR, Ross TM. Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity. Immunol Res. 2006;36:197–210. doi: 10.1385/IR:36:1:197. PubMed DOI

Kinoshita T. Biology of complement: the overture. Immunol Today. 1991;12:291–295. doi: 10.1016/0167-5699(91)90001-A. PubMed DOI

Thurman JM, Kulik L, Orth H, Wong M, Renner B, Sargsyan SA, Mitchell LM, et al. Detection of complement activation using monoclonal antibodies against C3d. J Clin Invest. 2013;123:2218–2230. doi: 10.1172/JCI65861. PubMed DOI PMC

Gierej B, Górnicka B, Wasiutyński A. Role of C3d and C4d complement fragments in the diagnostics of acute allograft rejection after transplantations. Ann Transplant. 2009;14:61–70. PubMed

Snijders MLH, van de Wall-Neecke BJ, Hesselink DA, Becker JU, Clahsen-van Groningen MC. Utility of immunohistochemistry with C3d in C3 glomerulopathy. Mod Pathol. 2020;33:431–439. doi: 10.1038/s41379-019-0348-z. PubMed DOI

Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant. 2011;11:450–462. doi: 10.1111/j.1600-6143.2010.03283.x. PubMed DOI

Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med. 2002;8:582–587. doi: 10.1038/nm0602-582. PubMed DOI

Corrêa RR, Machado JR, da Silva MV, Helmo FR, Guimarães CS, Rocha LP, Faleiros AC, dos Reis MA. The importance of C4d in biopsies of kidney transplant recipients. Clin Dev Immunol. 2013;2013:678180. doi: 10.1155/2013/678180. PubMed DOI PMC

Nankivell BJ, Alexander SI. Rejection of the kidney allograft. N Engl J Med. 2010;363:1451–1462. doi: 10.1056/NEJMra0902927. PubMed DOI

Eggertsen G, Nyberg G, Nilsson B, Nilsson U, Svalander CT. Complement deposition in renal allografts with early malfunction. APMIS. 2001;109:825–834. doi: 10.1034/j.1600-0463.2001.091204.x. PubMed DOI

Cornell LD. Histopathologic Features of Antibody Mediated Rejection: The Banff Classification and Beyond. Front Immunol. 2021;12:718122. doi: 10.3389/fimmu.2021.718122. PubMed DOI PMC

Ozaki M, Kang Y, Tan YS, Pavlov VI, Liu B, Boyle DC, Kushak RI, et al. Human mannose-binding lectin inhibitor prevents Shiga toxin-induced renal injury. Kidney Int. 2016;90:774–782. doi: 10.1016/j.kint.2016.05.011. PubMed DOI PMC

Okada M, Yoshioka K, Takemura T, Akano N, Aya N, Murakami K, Maki S. Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor. Virchows Arch A Pathol Anat Histopathol. 1993;422:367–373. doi: 10.1007/BF01605455. PubMed DOI

Leivo I, Engvall E. C3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblast. J Cell Biol. 1986;103:1091–1100. doi: 10.1083/jcb.103.3.1091. PubMed DOI PMC

Yatim KM, Azzi JR. Novel Biomarkers in Kidney Transplantation. Semin Nephrol. 2022;42:2–13. doi: 10.1016/j.semnephrol.2022.01.007. PubMed DOI

Sicard A, Ducreux S, Rabeyrin M, Couzi L, McGregor B, Badet L, Scoazec JY, et al. Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. J Am Soc Nephrol. 2015;26:457–467. doi: 10.1681/ASN.2013101144. PubMed DOI PMC

Sapir-Pichhadze R, Curran SP, John R, Tricco AC, Uleryk E, Laupacis A, Tinckam K, Sis B, Beyene J, Logan AG, Kim SJ. A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection. Kidney Int. 2015;87:182–194. doi: 10.1038/ki.2014.166. PubMed DOI

Kuypers DR, Lerut E, Evenepoel P, Maes B, Vanrenterghem Y, Van Damme B. C3D deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome. Transplantation. 2003;76:102–108. doi: 10.1097/01.TP.0000069040.16457.06. PubMed DOI

Pelletier RP, Balazs I, Adams P, Rajab A, DiPaola NR, Henry ML. Clinical utility of C3d binding donor-specific anti-human leukocyte antigen antibody detection by single antigen beads after kidney transplantation-a retrospective study. Transpl Int. 2018;31:424–435. doi: 10.1111/tri.13106. PubMed DOI

Lv R, Zhang W, Han F, Liu G, Xie W, Chen J. Capillary deposition of complement C4d and C3d in Chinese renal allograft biopsies. Dis Markers. 2015;2015:397613. doi: 10.1155/2015/397613. PubMed DOI PMC

Ma R, Cui Z, Hu SY, Jia XY, Yang R, Zheng X, Ao J, et al. The alternative pathway of complement activation may be involved in the renal damage of human anti-glomerular basement membrane disease. PLoS One. 2014;9:e91250. doi: 10.1371/journal.pone.0091250. PubMed DOI PMC

Villacorta J, Diaz-Crespo F, Acevedo M, Guerrero C, Campos-Martin Y, García-Díaz E, Mollejo M, Fernandez-Juarez G. Glomerular C3d as a novel prognostic marker for renal vasculitis. Hum Pathol. 2016;56:31–39. doi: 10.1016/j.humpath.2016.05.015. PubMed DOI

Zhang R, Lin J, Qu L, Zheng F, Zheng Z. C3d deposition in the media of renal arterioles is a useful marker for arteriolosclerosis in IgA nephropathy. Ann Diagn Pathol. 2014;18:104–108. doi: 10.1016/j.anndiagpath.2014.01.001. PubMed DOI

Boudhabhay I, Poillerat V, Grunenwald A, Torset C, Leon J, Daugan MV, Lucibello F, et al. Complement activation is a crucial driver of acute kidney injury in rhabdomyolysis. Kidney Int. 2021;99:581–597. doi: 10.1016/j.kint.2020.09.033. PubMed DOI

Pfister F, Vonbrunn E, Ries T, Jäck HM, Überla K, Lochnit G, Sheriff A, et al. Complement Activation in Kidneys of Patients With COVID-19. Front Immunol. 2021;11:594849. doi: 10.3389/fimmu.2020.594849. PubMed DOI PMC

Magro CM, Dyrsen ME. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease. J Am Acad Dermatol. 2008;59:822–833. doi: 10.1016/j.jaad.2008.06.022. PubMed DOI

Rosi-Schumacher M, Baker J, Waris J, Seiffert-Sinha K, Sinha AA. Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid. Front Immunol. 2023;14:1159351. doi: 10.3389/fimmu.2023.1159351. PubMed DOI PMC

Wang LL, Moshiri AS, Novoa R, Simpson CL, Takeshita J, Payne AS, Chu EY. Comparison of C3d immunohistochemical staining to enzyme-linked immunosorbent assay and immunofluorescence for diagnosis of bullous pemphigoid. J Am Acad Dermatol. 2020;83:172–178. doi: 10.1016/j.jaad.2020.02.020. PubMed DOI PMC

Oh H, Kim CH, Lee YJ. Bullous pemphigoid diagnosis: the role of routine formalin-fixed paraffin-embedded skin tissue immunochemistry. Sci Rep. 2022;12:10519. doi: 10.1038/s41598-022-14950-z. PubMed DOI PMC

Pfaltz K, Mertz K, Rose C, Scheidegger P, Pfaltz M, Kempf W. C3d immunohistochemistry on formalin-fixed tissue is a valuable tool in the diagnosis of bullous pemphigoid of the skin. J Cutan Pathol. 2010;37:654–658. doi: 10.1111/j.1600-0560.2009.01450.x. PubMed DOI

Guo L, Jacobson R, Vaughan H, Connolly MK, Seiger K, Haemel AK, North J. C3d immunohistochemistry in the diagnosis of bullous pemphigoid: A comparative diagnostic test accuracy and cost analysis study. J Am Acad Dermatol. 2023;89:413–415. doi: 10.1016/j.jaad.2023.04.016. PubMed DOI

Al-Shenawy HA. Can immunohistochemistry replace immunofluorescence in diagnosis of skin bullous diseases? APMIS. 2017;125:114–121. doi: 10.1111/apm.12643. PubMed DOI

Ashrafzadeh S, Fedeles F. What the rheumatologist needs to know about skin biopsy. Best Pract Res Clin Rheumatol. 2023:101838. doi: 10.1016/j.berh.2023.101838. PubMed DOI

Niebel D, de Vos L, Fetter T, Brägelmann C, Wenzel J. Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions. Am J Clin Dermatol. 2023;24:521–540. doi: 10.1007/s40257-023-00774-8. PubMed DOI PMC

Deng M, Zhou X, Zhang J, Li Y. Immunohistochemical analysis for C3d, C4d, IgG, IgG4, and CD123 in diagnosis of autoimmune skin diseases (Article in Chinese) Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019;44:878–884. PubMed

Deng M, Wu R, Zhou X, Su Y, Li Y. Analyses of the clinical and immunological characteristics of patients with lupus erythematosus. Indian J Dermatol. 2022;67:205. doi: 10.4103/ijd.ijd_942_20. PubMed DOI PMC

Tiller G, Lammerts RGM, Karijosemito JJ, Alkaff FF, Diepstra A, Pol RA, Meter-Arkema AH, et al. Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney. Front Immunol. 2022;13:845301. doi: 10.3389/fimmu.2022.845301. PubMed DOI PMC

Thurman JM, Kulik L, Orth H, Wong M, Renner B, Sargsyan SA, Mitchell LM, et al. Detection of complement activation using monoclonal antibodies against C3d. J Clin Invest. 2013;123:2218–2230. doi: 10.1172/JCI65861. PubMed DOI PMC

Bordron A, Bagacean C, Tempescul A, Berthou C, Bettacchioli E, Hillion S, Renaudineau Y. Complement System: a Neglected Pathway in Immunotherapy. Clin Rev Allergy Immunol. 2020;58:155–171. doi: 10.1007/s12016-019-08741-0. PubMed DOI